Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
about
An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein.HIV-1 Vif and APOBEC3G: multiple roads to one goalHIV-1 Vif, APOBEC, and intrinsic immunityInhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationComprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virionsFeline immunodeficiency virus Vif localizes to the nucleusSIV replication in human cellsThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity.Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration.Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nefgag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitroCellular and viral specificities of human immunodeficiency virus type 1 vif protein.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Functional roles of equine infectious anemia virus Gag p9 in viral budding and infectionHuman immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.Potent suppression of viral infectivity by the peptides that inhibit multimerization of human immunodeficiency virus type 1 (HIV-1) Vif proteins.Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection.Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif.A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV.TOX4 and NOVA1 proteins are partners of the LEDGF PWWP domain and affect HIV-1 replicationResidual HIV-1 DNA Flap-independent nuclear import of cPPT/CTS double mutant viruses does not support spreading infectionBiological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains.The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexesvif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.Characterization of human immunodeficiency virus type 1 Vif particle incorporation.Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins.Role of Vif in human immunodeficiency virus type 1 reverse transcriptionThe Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cellsVif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.Peptide inhibitors of HIV-1 protease and viral infection of peripheral blood lymphocytes based on HIV-1 Vif.
P2860
Q24523705-77996F87-91BC-4A61-9DFE-DBC9EFAC1D50Q24564072-59EA3819-1C7A-4B57-871F-5F37D942F7E0Q24647833-AE727E5E-E7B3-44D5-9803-B8476BA6C2F7Q24669993-C905076D-1267-43C3-BA19-73FA3193BE73Q24678970-F1983D7A-0E3A-4363-8D4A-67969F3B308AQ27469637-AEC15126-5E21-46E8-B17D-C6A367792E27Q30417737-DF1FC4A9-EBB2-46AA-809B-1F5392D0F814Q30440445-5427F705-BA2C-408C-972F-5C0C6DD5006BQ30860339-4A387B03-473F-449A-BB5E-DCFA6344CF23Q31011512-49AA85A2-271A-4377-84D4-C4FC587F4BC9Q31103609-688B1399-25CF-48FE-9103-46C0BA54B49EQ33768829-30C852A4-DD33-4AE4-A920-7CB6350C2C6CQ33782866-542DE21B-CECE-4903-A250-1521A6173D83Q33785006-44533079-DA03-496C-AFDC-2E4F1E4343BAQ33806688-78A81F17-F80B-46FF-847B-C97BB7218F06Q33841920-06A3C654-769F-4E7C-9B6E-CCB1A94182B9Q33846683-509CE0F4-4E8F-4F0F-97A2-43257F1236CFQ33852465-59B2F394-D6D2-49A4-9F29-DC96BF071A01Q34062105-7A7DC72D-F74E-49F6-91DC-F690277480CFQ34312616-3C4E27B3-23B5-4ED9-A616-2DF0422EFE7CQ34345408-507D863D-8EAC-4651-8FAE-31F299A4ECC7Q34465108-1A349DD6-07E5-4747-AA80-8E706AC999C0Q34465355-EE36F53A-1B3A-4778-BF6A-C6FA29776CE3Q34552313-047EF5AD-233C-4BB3-B937-111101096B56Q35060475-E9D35E5E-EE00-4223-B082-D06AF9B1FBC4Q35582736-88650CCD-7D47-4303-9AFE-90B909B41185Q35851202-E08AD099-F5B2-45CD-97C1-F06389F9EB26Q35851966-E01BACFE-0C87-49A4-BE22-8AD1AA3EF48DQ35856279-3DCF3D31-689C-4054-9F47-7A4A949000D1Q35866134-904B3DCE-4C75-4A23-B4EF-8C197BCC8314Q35866177-C49B4D6D-CFEE-42CD-AD57-22494EF21A77Q35866513-AD80E868-3955-4BBC-B03A-DA3D98BC0D35Q35868144-A2EB03BD-6072-4623-B801-009CC23E1C8FQ35873067-EF7B4E55-EB8F-4D4C-A0B9-9F46261D1320Q35873743-E39C8A2B-97FB-4C67-9F63-0337E31CDB16Q35888172-C4BF9E7E-0042-46CD-9AF3-711C041D16E2Q35990905-3C83AAD5-349A-41B9-B2E5-65D36F4B3876Q36484144-7F856D9D-4550-4303-BBB3-AC84B04AC704Q36548864-2DFE184D-14BF-4CD0-82CB-8650919A52C1Q36805150-58145DF0-E6FE-42A9-BBF0-791D1DFA6C96
P2860
Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Human immunodeficiency virus t ...... icle assembly and infectivity.
@en
Human immunodeficiency virus t ...... icle assembly and infectivity.
@nl
type
label
Human immunodeficiency virus t ...... icle assembly and infectivity.
@en
Human immunodeficiency virus t ...... icle assembly and infectivity.
@nl
prefLabel
Human immunodeficiency virus t ...... icle assembly and infectivity.
@en
Human immunodeficiency virus t ...... icle assembly and infectivity.
@nl
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... ticle assembly and infectivity
@en
P2093
P2860
P304
P407
P50
P577
1995-04-01T00:00:00Z